Can Tirzepatide Help You Lose Weight?
US$ 29.55
glp 1 agonists tirzepatide GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 GLP-1 Vs Tirzepatide: Powerful Guide
Description
Tirzepatides unique action on GLP-1 and GIP receptors makes it effective for weight loss
In the SCALE trial, patients receiving liraglutide lost an average 5.6 kg (~12 lbs) more than patients receiving placebo, which translated to a 5.4% body weight loss over the course of 56 weeks (NCT01272219)
placebo)
Survodutide: Dual GLP-1R/GCGR agonist with glucagon-favoring activity ratio (~4-5x GCGR vs GLP-1R)
"Without the usual controls, there are a lot of unknowns, and this translates into more risk for you," he warned
